D'Orazio & Associates, Inc. Viatris Inc Transaction History
D'Orazio & Associates, Inc.
- $703 Million
- Q3 2024
A detailed history of D'Orazio & Associates, Inc. transactions in Viatris Inc stock. As of the latest transaction made, D'Orazio & Associates, Inc. holds 13,243 shares of VTRS stock, worth $164,213. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,243
Previous 13,243
-0.0%
Holding current value
$164,213
Previous $140,000
9.29%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding VTRS
# of Institutions
1,102Shares Held
933MCall Options Held
2.71MPut Options Held
2.4M-
Vanguard Group Inc Valley Forge, PA141MShares$1.75 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.15 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$783 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$777 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$605 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...